Sartorius Aktiengesellschaft (OTCMKTS:SUVPF – Get Rating) had its price target cut by stock analysts at JPMorgan Chase & Co. from €665.00 ($671.72) to €570.00 ($575.76) in a report released on Friday, The Fly reports.
SUVPF has been the subject of several other reports. Deutsche Bank Aktiengesellschaft reduced their target price on Sartorius Aktiengesellschaft from €650.00 ($656.57) to €518.00 ($523.23) and set a “buy” rating for the company in a research note on Tuesday, July 5th. Morgan Stanley upped their target price on Sartorius Aktiengesellschaft from €520.00 ($525.25) to €540.00 ($545.45) in a research note on Friday.
Sartorius Aktiengesellschaft Stock Performance
Sartorius Aktiengesellschaft stock opened at $349.93 on Friday. The stock’s 50 day simple moving average is $333.72 and its two-hundred day simple moving average is $416.57. Sartorius Aktiengesellschaft has a 12 month low of $305.00 and a 12 month high of $736.22.
Sartorius Aktiengesellschaft Company Profile
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents.
Featured Stories
Receive News & Ratings for Sartorius Aktiengesellschaft Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Sartorius Aktiengesellschaft and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: defenseworld.net
